In this webinar, fertility experts Dr. Ashok Agarwal, PhD, and Dr. Botros Peter Rizk, MD, MA, FRCOG, FRCS, HCLD, FACOG, FACS, will discuss how oxidative stress impacts male and female fertility, and the research supporting oral supplementation with antioxidants for improving fertility.

Dr. Agarwal will discuss the factors responsible for the rise in male infertility. Increasing evidence suggests that oxidative stress (OS) plays an independent role in the etiology of male infertility, with 30% to 80% of infertile men having elevated seminal reactive oxygen species levels. He will explain how OS can negatively affect fertility via a number of pathways, which may impair the sperm’s potential to fertilize an egg and develop into a healthy embryo. And Dr. Agarwal will discuss how the use of antioxidants to reduce oxidative stress across a range of etiologies and risk factors of male infertility is gaining much attention.

Dr. Rizk will share clinical study data showing the impact that antioxidants can have on IVF outcomes when added to culture medium. He will also discuss the results of a recent clinical trial evaluating the benefit of oral antioxidant supplementation on clinical pregnancy rates in IVF patients. and when taken orally.

In this webinar, you’ll:

  • Understand oxidative stress and its impact on male and female fertility, including the impact of oxidative stress in the etiology of endometriosis, PCOS, and suboptimal sperm function
  • Review new clinical trials on the use of antioxidants for supporting male and female fertility
  • Examine antioxidants as a therapeutic intervention

Please note, Fairhaven Health products are only available on Fullscript’s US catalog.

Save my spot

Can’t make the scheduled date? Register anyway! We’ll be sending a recording to all registrants after the event.

Ashok Agarwal received his Ph.D. in 1983 from Banaras Hindu University, India. Ashok was appointed in 1993 by the Cleveland Clinic Foundation, Ohio, as the Head of the Clinical Andrology Center, which over 28 years under his leadership, has become a center of excellence in the United States for the diagnosis of male infertility and fertility preservation of men with oncological conditions. He is board certified as a Clinical Laboratory Director in Andrology by the American Board of Bioanalysis and an Inspector for the College of American Pathologists “Reproductive Laboratory Program” for accreditation of Andrology & IVF Laboratories.

Dr. Rizk has published over twenty medical textbooks covering various aspects of infertility, ultrasonography and robotic surgery and is one of the early members of European Society for Human Reproduction in addition to being a founding member of Middle East Fertility Society.
Studying under Nobel Laureate Professor Robert Edwards, a recipient of the nobel prize in Medicine for the world’s first successful In Vitro fertilization treatment, Dr. Rizk began his career in Reproductive Medicine in London and Cambridge and later joined the prestigious University of Cambridge as faculty from 1990 to 1993. Dr. Rizk is board certified by the American Board of Obstetrics & Gynecology, the Royal College of Obstetricians & Gynecologists in England, the Royal College of Physicians & Surgeons of Canada in addition to the American Board of Bioanalysts in Embryology & Andrology.